LNG exporter Venture Global slashes IPO price range

Venture Global LNG raises $1.75 billion after pricing US IPO
Venture Global LNG has raised $1.75 billion after pricing its U.S. initial public offering within range, the second-largest exporter of liquefied natural gas in the United States said on Thursday. The company priced its offering of 70 million shares at $25 each,
Venture Global Slashes IPO Price Range by More Than 40%
Venture Global Inc. slashed the marketed range for its initial public offering, lowering the market value it could fetch.
Venture Global Slices Target Price as Year's First Big IPO Stumbles
Venture Global and the bankers helping to take it public hoped to capitalize on President Trump’s pro-oil-and-gas agenda. Instead, the gas exporter met pushback from prospective investors, and slashed its target price by more than one-third Wednesday.
LNG exporter Venture Global cuts target valuation for US IPO to $65.3 billion
Venture Global LNG on Wednesday slashed the valuation it sought from a U.S. initial public offering to $65.33 billion, significantly lower than the initial target of $110 billion.
LNG exporter Venture Global slashes IPO valuation target by $45B after investors balk
Liquefied natural gas producer Venture Global slashed the proposed range for its IPO on Wednesday, lowering the valuation it sought to ~$65B from the initial target of $110B at the top of the previous range.
Venture Global LNG reportedly considering lowering US IPO price range
The company plans to increase its share offering from 50 million to up to 62 million in its potential New York flotation.
Venture Global LNG raises $1.75 bln after pricing US IPO
Venture Global LNG has raised $1.75 billion after pricing its U.S. initial public offering, the second-largest exporter of liquefied natural gas in the United States said on Thursday.
Philippine water company Maynilad hires banks for over $500 million IPO, sources say
Maynilad Water Services has hired banks including Morgan Stanley and UBS to work on a more than $500 million initial public ...
Diabetes startup Virta Health is now prescribing Ozempic for weight loss in a push toward profitability and IPO
The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...
Travel App Hopper Eyes Long-Term IPO Plan, $10 Billion Valuation
Travel data provider Hopper Inc., one of Canada’s largest closely held technology companies, is eyeing a public listing that ...
ANG.PR.D: A 7.375% Preferred Shares IPO From American National Group
Financial analysis of American National Group's preferred stock ANG-D reveals concerns about dividend payments and market ...
Cathie Wood Sees Trump's Second Term Reviving IPO Market, Unlocking Opportunities In Biotech And AI Sectors
Renowned investor Cathie Wood, CEO of Ark Invest believes President Donald Trump's second administration could breathe new ...
Aardvark Therapeutics Files for IPO
Aardvark said it applied to list on the Nasdaq Global Market under the symbol AARD. The company didn't give an expected size for its IPO, nor did it offer an expected price range. Morgan Stanley, B of ...
IPO-bound Infra.Market raises $121 million
Infra.Market, a profitable B2B startup founded in 2016, has raised $121 million at a valuation of $2.8 billion in a pre-IPO ...
Odyssey Therapeutics Begins IPO Rollout
Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...
FierceBiotech2d
Odyssey, Sionna join band of biotechs ready to brave thawing IPO waters in 2025
Odyssey Therapeutics and Sionna Therapeutics have filed IPO paperwork, swelling the pack of startups that will provide an ...